Yearly Archives: 2025

National Patient Safety Alert: Potential contamination of non-sterile alcohol-free skin cleansing wipes with Burkholderia spp: measures to reduce patient risk National Patient Safety Alert Reference Number:  NatPSA/2025/002/UKHSA Date of issue: 26/06/2025 Explanation of identified safety issue UKHSA is investigating an outbreak of Burkholderia stabilis involving individuals across the UK, linked to wipes. Following testing, Burkholderia [...]

The post National Patient Safety Alert: Potential contamination of non-sterile alcohol-free skin cleansing wipes with Burkholderia spp: measures to reduce patient risk appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (26/06/2025) confirmed the following list of price concessions for June 2025: Drug Pack size Price concession Acetazolamide 250mg tablets 112 £75.25 Alendronic acid 70mg tablets 4 £0.99 Buprenorphine 2mg sublingual tablets sugar free 7 £1.48 Buprenorphine 8mg sublingual tablets sugar free 7 £4.59 Carbocisteine 375mg capsules [...]

The post June 2025 Price Concessions 2nd Update appeared first on Community Pharmacy England.

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 July 2025. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...]

The post Drug Tariff Watch – July 2025 appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England, the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), several changes have been agreed within the July 2025 Drug Tariff associated with Advanced services and the Essential service, the Discharge Medicines Service (DMS). Changes to reflect the simplified DMS journey on MYS As [...]

The post Advanced and Essential service changes in the July Drug Tariff appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Notification: Depo-Medrone 80 mg in 2 mL (Maxearn Limited) Drug alert number: EL(25)A/29 Date issued: 25 June 2025 A batch of Depo-Medrone has been released to the market with an error. The vial over label incorrectly states that the total vial content is 40 mg in 1 mL, when the correct [...]

The post MHRA Class 2 Medicines Recall: Depo-Medrone 80 mg in 2 mL (Maxearn Limited) appeared first on Community Pharmacy England.